‘Guided Missile Drugs’ Could Be Big Pharma’s Secret Weapon

[ad_1] Merck and Pfizer are the latest big pharma companies to invest in this booming area. [ad_2] Source link

This $5 Billion Biotech Home Run Took Less Than a Year

[ad_1] You can’t completely blame Pfizer’s executives, yet Roche’s $7 billion acquisition of a bowel-disease treatment that it owned until last year isn’t a great look. In a deal that…

Roche to Buy Bowel-Disease Drug From Roivant, Pfizer for More Than $7 Billion

[ad_1] Updated Oct. 23, 2023 6:55 am ET Roche Holding has agreed to buy the developer of a bowel-disease treatment from Roivant Sciences, a company started by Republican presidential candidate…

Pfizer Looks for a Covid Bottom

[ad_1] What to Read Next [ad_2] Source link

Stocks Rise, Bond Prices Decline to Start Week

[ad_1] What to Read Next [ad_2] Source link

The Big Pharma Stock Trade: Weight Loss Is In, Covid-19 Is Out

[ad_1] What to Read Next [ad_2] Source link

Stocks Tick Up in Quiet Session Ahead of Fed Decision

[ad_1] U.S. stocks inched higher Monday, with technology shares stabilizing after slumping at the end of last week. [ad_2] Source link

CDC Advisers Endorse Covid-19 Boosters For Everyone Aged 6 Months And Older

[ad_1] The FDA cleared shots from Pfizer and Moderna that are expected to protect against latest Omicron subvariants. [ad_2] Source link

FDA Approves Newest Covid-19 Boosters

[ad_1] Vaccine specialists say the updated shots should protect against strains now circulating. The boosters should be available within days. [ad_2] Source link

Big Pharma’s Battle With the Biden Administration Could Have Legs

[ad_1] Wall Street should pay attention as the pharma industry mounts a widening legal campaign against the Inflation Reduction Act. [ad_2] Source link